Alterity Therapeutics (ATHE) Other Working Capital Changes (2009 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Other Working Capital Changes of $10868.2 for Q2 2020, down 67.24% year-over-year from $33175.8 in Q3 2019, and up 154.08% quarter-over-quarter from $4277.4 in Q4 2019.
Alterity Therapeutics (ATHE) Other Working Capital Changes (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Other Working Capital Changes history runs 11 years deep, the most recent figure standing at $10868.2 for Q2 2020.
- In Q2 2020, Other Working Capital Changes fell 67.24% year-over-year to $10868.2; the TTM figure through Jun 2020 stood at $75696.5 (down 48.31% YoY), while the FY2025 annual figure was $221083.3, up 253.88% from the prior year.
- Other Working Capital Changes for Q2 2020 stood at $10868.2, up from $4277.4 in the prior quarter.
- The five-year high for Other Working Capital Changes was $46670.6 in Q4 2017, with the low at -$255773.2 in Q2 2019.
- The 5-year median for Other Working Capital Changes is -$86350.9 (2016), against an average of -$77106.7.
- The sharpest annual moves came in 2016 and 2019: Other Working Capital Changes slumped 647.28% in 2016, then jumped 4125.31% in 2019.
- Alterity Therapeutics' Other Working Capital Changes stood at -$90727.9 in 2016, then jumped by 195.57% to $86708.3 in 2017, then slumped by 68.43% to $27375.1 in 2018, then slumped by 84.37% to $4277.4 in 2019, then soared by 154.08% to $10868.2 in 2020.
- Business Quant data shows ATHE's Other Working Capital Changes at $10868.2 in Q2 2020, $4277.4 in Q4 2019, and $33175.8 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - |
| 10 | Alterity Therapeutics | 48.99 Mn | 16.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 10,868.18 |
| Jun 30, 2020 | 10,868.18 |
| Jun 30, 2020 | 10,868.18 |
| Dec 31, 2019 | 4,277.45 |
| Dec 31, 2019 | 4,277.45 |
| Dec 31, 2019 | 4,277.45 |
| Jun 30, 2019 | 33,175.77 |
| Jun 30, 2019 | 33,175.77 |
| Jun 30, 2019 | 33,175.77 |
| Dec 31, 2018 | 27,375.13 |
| Dec 31, 2018 | 27,375.13 |
| Dec 31, 2018 | 27,375.13 |
| Jun 30, 2018 | -824.18 |
| Jun 30, 2018 | -824.18 |
| Jun 30, 2018 | -824.18 |
| Dec 31, 2017 | 86,708.33 |
| Dec 31, 2017 | 86,708.33 |
| Dec 31, 2017 | 86,708.33 |
| Jun 30, 2017 | 67,035.76 |
| Jun 30, 2017 | 67,035.76 |